Follicular involvement is frequent in lentigo maligna: Implications for treatment - 14/01/19
Abstract |
Background |
Follicular involvement of lentigo maligna (LM) is considered a histopathologic hallmark, but its prevalence and characteristics have not been well defined. The depth of intrafollicular extension by neoplastic melanocytes may have clinical importance in the treatment of LM.
Objective |
To describe the prevalence and features of follicular involvement in LM, including depth of follicular growth by melanocytes.
Methods |
A single-center retrospective study of 100 consecutive cases of surgically excised LM that was treated from 2013 to 2015. The slide review for cases with residual LM on the debulk specimen was performed by a dermatologic surgeon and dermatopathologist to characterize follicular involvement.
Results |
Of 100 specimens, 72 met the inclusion criteria for histopathologic evaluation. Follicular involvement was seen in 95.8% of specimens (95% confidence interval, 88.3%-99.1%), with a mean of 68% of follicles involved in a single specimen. The mean depth of intrafollicular growth by lesional melanocytes was 0.45 mm (standard deviation, 0.23; range, 0.1-1.1 mm). Tumor cells were confined to the infundibular portion of the hair follicle in 60.9% of specimens.
Conclusion |
Superficial follicular involvement is a ubiquitous finding in LM. When treatment options for LM with a depth-dependent modality aiming for tumor clearance are being considered, mean and maximum depths of involvement should be taken into consideration.
Le texte complet de cet article est disponible en PDF.Key words : adnexa, follicular involvement, lentigo maligna, melanoma
Abbreviations used : CI, LM, LMM, MIS, PSU, SD
Plan
Dr Connolly and Dr Giordano are cofirst authors. |
|
Funding sources: Supported in part through a National Institutes of Health/National Cancer Institute Cancer Center Support Grant (P30 CA008748). |
|
Conflicts of interest: None disclosed. |
|
Presented as a poster at the 49th Annual American College of Mohs Surgery Meeting, San Francisco, CA; April 27-30, 2017. |
|
Reprints not available from the authors. |
Vol 80 - N° 2
P. 532-537 - février 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?